Crawford Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55.9M | Sell |
1,991,614
-91,017
| -4% | -$2.42M | 0.96% | 34 |
|
|
2025
Q4 | $51.9M | Sell |
2,082,631
-72,614
| -3% | -$1.83M | 0.86% | 36 |
|
|
2025
Q3 | $54.9M | Buy |
2,155,245
+12,933
| +0.6% | +$319K | 0.91% | 36 |
|
|
2025
Q2 | $51.9M | Sell |
2,142,312
-34,646
| -2% | -$808K | 0.91% | 37 |
|
|
2025
Q1 | $55.2M | Buy |
2,176,958
+189,933
| +10% | +$4.97M | 0.98% | 38 |
|
|
2024
Q4 | $52.7M | Buy |
1,987,025
+141,653
| +8% | +$3.84M | 0.95% | 39 |
|
|
2024
Q3 | $53.4M | Buy |
1,845,372
+27,448
| +2% | +$801K | 0.91% | 41 |
|
|
2024
Q2 | $50.9M | Buy |
1,817,924
+40,585
| +2% | +$1.12M | 0.97% | 38 |
|
|
2024
Q1 | $49.3M | Buy |
1,777,339
+224,802
| +14% | +$6.24M | 0.92% | 40 |
|
|
2023
Q4 | $44.7M | Buy |
1,552,537
+129,770
| +9% | +$3.92M | 0.9% | 41 |
|
|
2023
Q3 | $47.2M | Buy |
1,422,767
+29,633
| +2% | +$1.05M | 1.02% | 39 |
|
|
2023
Q2 | $51.1M | Buy |
1,393,134
+158,417
| +13% | +$6.17M | 1.04% | 40 |
|
|
2023
Q1 | $50.4M | Buy |
1,234,717
+612,949
| +99% | +$26.5M | 1.08% | 40 |
|
|
2022
Q4 | $31.9M | Sell |
621,768
-10,741
| -2% | -$515K | 0.69% | 42 |
|
|
2022
Q3 | $27.7M | Buy |
632,509
+17,695
| +3% | +$860K | 0.65% | 43 |
|
|
2022
Q2 | $32.2M | Buy |
614,814
+5,526
| +0.9% | +$282K | 0.71% | 42 |
|
|
2022
Q1 | $31.5M | Sell |
609,288
-38,691
| -6% | -$2.01M | 0.61% | 42 |
|
|
2021
Q4 | $38.3M | Sell |
647,979
-30,546
| -5% | -$1.51M | 0.73% | 43 |
|
|
2021
Q3 | $29.2M | Sell |
678,525
-47,297
| -7% | -$2.1M | 0.6% | 44 |
|
|
2021
Q2 | $28.4M | Buy |
725,822
+25,711
| +4% | +$1,000K | 0.57% | 44 |
|
|
2021
Q1 | $25.4M | Buy |
700,111
+49,174
| +8% | +$1.75M | 0.57% | 45 |
|
|
2020
Q4 | $24M | Buy |
650,937
+29,317
| +5% | +$1.08M | 0.59% | 46 |
|
|
2020
Q3 | $21.6M | Buy |
621,620
+69,246
| +13% | +$2.43M | 0.59% | 46 |
|
|
2020
Q2 | $17.1M | Buy |
552,374
+78,148
| +16% | +$2.65M | 0.49% | 48 |
|
|
2020
Q1 | $14.7M | Buy |
474,226
+359,148
| +312% | +$12.2M | 0.49% | 50 |
|
|
2019
Q4 | $4.28M | Sell |
115,078
-4,149
| -3% | -$148K | 0.11% | 115 |
|
|
2019
Q3 | $4.06M | Sell |
119,227
-11,829
| -9% | -$430K | 0.11% | 106 |
|
|
2019
Q2 | $5.39M | Sell |
131,056
-10,709
| -8% | -$425K | 0.15% | 86 |
|
|
2019
Q1 | $5.71M | Sell |
141,765
-55,451
| -28% | -$2.22M | 0.17% | 83 |
|
|
2018
Q4 | $8.17M | Sell |
197,216
-241,010
| -55% | -$10M | 0.28% | 73 |
|
|
2018
Q3 | $18.3M | Sell |
438,226
-16,235
| -4% | -$625K | 0.56% | 47 |
|
|
2018
Q2 | $15.6M | Sell |
454,461
-22,462
| -5% | -$768K | 0.5% | 53 |
|
|
2018
Q1 | $16.1M | Sell |
476,923
-3,110
| -0.6% | -$107K | 0.51% | 55 |
|
|
2017
Q4 | $16.5M | Sell |
480,033
-1,020
| -0.2% | -$34.8K | 0.51% | 56 |
|
|
2017
Q3 | $16.3M | Buy |
481,053
+2,362
| +0.5% | +$75.9K | 0.53% | 53 |
|
|
2017
Q2 | $15.3M | Buy |
478,691
+359,636
| +302% | +$11.3M | 0.53% | 55 |
|
|
2017
Q1 | $3.86M | Sell |
119,055
-2,069
| -2% | -$65.2K | 0.14% | 81 |
|
|
2016
Q4 | $3.73M | Buy |
121,124
+1,016
| +0.8% | +$31K | 0.14% | 87 |
|
|
2016
Q3 | $3.86M | Sell |
120,108
-986
| -0.8% | -$33K | 0.14% | 84 |
|
|
2016
Q2 | $4.04M | Sell |
121,094
-2,744
| -2% | -$87.6K | 0.16% | 79 |
|
|
2016
Q1 | $3.48M | Sell |
123,838
-14,204
| -10% | -$406K | 0.15% | 81 |
|
|
2015
Q4 | $4.23M | Sell |
138,042
-5,510
| -4% | -$173K | 0.19% | 77 |
|
|
2015
Q3 | $4.28M | Buy |
143,552
+1,870
| +1% | +$60K | 0.19% | 75 |
|
|
2015
Q2 | $4.51M | Sell |
141,682
-1,387
| -1% | -$45.2K | 0.17% | 77 |
|
|
2015
Q1 | $4.72M | Buy |
143,069
+2,004
| +1% | +$63.7K | 0.17% | 73 |
|
|
2014
Q4 | $4.17M | Sell |
141,065
-2,773
| -2% | -$79.5K | 0.15% | 78 |
|
|
2014
Q3 | $4.04M | Sell |
143,838
-4,270
| -3% | -$120K | 0.15% | 76 |
|
|
2014
Q2 | $4.17M | Buy |
148,108
+12,971
| +10% | +$370K | 0.15% | 65 |
|
|
2014
Q1 | $4.12M | Sell |
135,137
-689
| -0.5% | -$20.5K | 0.15% | 59 |
|
|
2013
Q4 | $3.95M | Buy |
135,826
+3,130
| +2% | +$91.1K | 0.14% | 61 |
|
|
2013
Q3 | $3.62M | Sell |
132,696
-2,317
| -2% | -$63K | 0.14% | 62 |
|
|
2013
Q2 | $3.59M | Buy |
+135,013
| New | +$3.73M | 0.15% | 57 |
|
Other funds holding PFE
VCM
VPM
Crawford Investment Counsel's PFE Position: Q1 2026 in Review
Crawford Investment Counsel reduced its Pfizer (PFE) stake by 4.4% in Q1 2026, selling an estimated $2.42M and leaving 1,991,614 shares worth $55.9M. The position accounts for 0.96% of the portfolio, ranked #34.
Crawford Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Crawford Investment Counsel held 1,991,614 shares of Pfizer worth $55.9M as of Q1 2026.
- Crawford Investment Counsel sold 91,017 Pfizer shares in Q1 2026, an estimated $2.42M.
- Pfizer made up 0.96% of Crawford Investment Counsel's portfolio in Q1 2026, its #34 holding.
- Crawford Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.